Compared to other inflammatory markers like C-reactive protein or interleukin-6, UHR offers a unique advantage by integrating both pro-oxidative (UA) and protective (HDL-C) components, providing a more holistic reflection of metabolic-inflammatory imbalance in T2DM-related CKD. This evidence concerns the gene IL6 and chronic kidney disease.